Day One Biopharmaceuticals Inc. (DAWN) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Day One Biopharmaceutical...

    NASDAQ: DAWN · Real-Time Price · USD
    7.26
    -0.15 (-2.02%)
    At close: Sep 10, 2025, 3:59 PM
    7.26
    0.00%
    After-hours: Sep 10, 2025, 04:20 PM EDT

    Day One Biopharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -12.42 -6.17 -10.66 -14.82
    PEG Ratio
    		 0.22 -0.36 -0.14 -0.2
    PS Ratio
    		 9.04 n/a n/a n/a
    PB Ratio
    		 2.36 3.36 -5.22 -8.19
    P/FCF Ratio
    		 -14.78 -7.76 -12.82 -18.46
    P/OCF Ratio
    		 -15.19 -7.93 -12.82 -21.51
    OCF/S Ratio
    		 -0.6 n/a n/a n/a
    Debt / Equity Ratio
    		 0.01 0.00 -0.00 -0.00
    Quick Ratio
    		 7.61 12.72 20.94 33.43
    Current Ratio
    		 7.66 12.72 20.94 33.43
    Asset Turnover
    		 0.23 n/a n/a n/a
    Interest Coverage
    		 n/a n/a -30.95 -18.19K
    Return on Equity
    		 -0.19 -0.55 0.49 0.55
    Return on Assets
    		 -0.16 -0.5 -0.38 -0.24
    Return on Invested Capital
    		 -0.39 -0.59 -0.41 -0.26
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.96 n/a n/a n/a
    Net Profit Margin
    		 -0.73 n/a n/a n/a
    Pretax Profit Margin
    		 -0.67 n/a n/a n/a
    Operating Profit Margin
    		 -1.66 n/a n/a n/a
    FCF Margin
    		 -0.61 n/a n/a n/a
    EBITDA Margin
    		 -1.66 n/a n/a n/a

    Add to Watchlist